Nalmefene
Sponsors
Somaxon Pharmaceuticals, H. Lundbeck A/S, Central Institute of Mental Health, Mannheim, University of Bordeaux, National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Conditions
AUDAlcohol DependenceAlcohol UseAlcohol Use DisorderAlcoholismAnesthesiaBehavioural AddictionBorderline Personality Disorder
Early Phase 1
Phase 1
Title: Effect of Opioid Receptor Modulation on Alcohol Self-Administration and Neural Response to Alcohol Cues in Heavy Drinkers: Role of OPRM1 Gene Variation
CompletedNCT02639273
Start: 2016-06-08End: 2023-12-08Updated: 2025-11-21
Pharmacokinetic Evaluation of Nalmefene Administered Intranasally to Healthy Volunteers
CompletedNCT03129347
Start: 2017-06-01End: 2017-07-03Updated: 2018-03-26
St. PETERsburg Pain and Alcohol Intervention With Naltrexone and Nalmefene
CompletedNCT03278886
Start: 2018-07-03End: 2018-12-19Updated: 2020-08-24
Patient Driven Recovery With Nalmefene and Coaching
CompletedNCT03279562
Start: 2017-09-01End: 2019-12-30Updated: 2021-01-22
Pharmacokinetic Evaluation of Intranasal Nalmefene
CompletedNCT04759768
Start: 2021-02-08End: 2021-05-24Updated: 2024-08-13
An Evaluation of The Absolute Bioavailability of TH104
CompletedNCT06198686
Start: 2024-01-26End: 2024-11-06Updated: 2025-04-08
Phase 2
Nalmefene Smoking Cessation Study
CompletedNCT00202696
Start: 2005-09-30End: 2006-03-31Updated: 2008-05-19
Evaluation of Nalmefene in Impulse Control Disorders in Parkinson's Disease: A Prospective Open Label Study
NCT02934919
Start: 2016-12-31End: 2018-05-31Target: 30Updated: 2016-10-17
Nalmefene, Baclofen and Impulsivity in Subjects With Alcohol Use Disorder and Healthy Control Subjects
CompletedNCT03034408
Start: 2016-07-01End: 2018-12-17Updated: 2020-10-29
TH104 for the Treatment of Pruritus in Primary Biliary Cholangitis
Not yet recruitingNCT06733519
Start: 2026-06-01End: 2027-06-01Target: 40Updated: 2025-09-09
Phase 3
Efficacy of Nalmefene in Patients With Alcohol Dependence
CompletedNCT00811720
Start: 2008-12-31End: 2010-11-30Updated: 2013-07-09
Safety and Efficacy of Nalmefene in Patients With Alcohol Dependence
CompletedNCT00811941
Start: 2009-03-31End: 2010-11-30Updated: 2013-08-07
Efficacy of Nalmefene in Patients With Alcohol Dependence
CompletedNCT00812461
Start: 2009-03-31End: 2011-04-30Updated: 2013-07-22
NAlmefene Versus Placebo in Addition to Treatment as Usual on Craving in Behavioural Addictions
RecruitingNCT05540288
Start: 2023-03-31End: 2027-07-31Target: 266Updated: 2025-02-12
Phase 4
Treatment of Patients Suffering of Alcohol Dependence and Impaired Liver Function With Selincro® As-needed Use
CompletedNCT02197598
Start: 2014-09-30Updated: 2016-12-14
Effect of Nalmefene on the Quality of Resuscitation in Patients Under General Anesthesia
CompletedNCT04713358
Start: 2021-09-24End: 2023-12-31Updated: 2026-02-25
Unknown Phase
Use of Selincro and Impact on Usual Practice
CompletedNCT02492581
Start: 2016-02-29End: 2018-04-30Updated: 2018-05-14
Nalmefene in Alcohol Dependence and Borderline Personality Disorder
NCT02752503
Start: 2015-03-31Target: 30Updated: 2016-04-27
Effect of Dexmedetomidine Combined With Low-dose Nalmefene on Preventing Remifentanil-induced Postoperative Hyperalgesia
CompletedNCT03096730
Start: 2017-02-06End: 2017-12-30Updated: 2021-08-03